| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/02/2008 | CN101152148A Kusnezoff monkshood root esculin microemulsion and its preparation |
| 04/02/2008 | CN101152147A Ligustrazine compound emulsion and method for preparing the same |
| 04/02/2008 | CN101152146A Hydrochloric acid olprinone injection and method for preparing the same |
| 04/02/2008 | CN101152145A Sugar-free type armillarisin oral solution |
| 04/02/2008 | CN101152144A Buccal preparation containing levorotation ofloxacin and method for preparing the same |
| 04/02/2008 | CN101152143A Solid pharmaceutical composition containing agomelatine |
| 04/02/2008 | CN101152142A Solid pharmaceutical composition containing 2-(3-cyano-4- isobutoxy phenyl)-4-methyl-5-thiazole methanoic acid |
| 04/02/2008 | CN100378118C Pharmaceutical compositions having appetite suppressant activity |
| 04/02/2008 | CN100378116C High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 04/02/2008 | CN100378108C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2008 | CN100377771C Emulsions including surface-modified organic molecules |
| 04/02/2008 | CN100377746C Method of stabilizing preparation |
| 04/02/2008 | CN100377745C Stabilized medicine preparation form with by porous kietyoite covering flavour |
| 04/02/2008 | CN100377742C Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 04/02/2008 | CN100377736C Proteinuria treating Chinese medicine and its preparing method and use |
| 04/02/2008 | CN100377735C Ganoderma lucidum buccal tablet |
| 04/02/2008 | CN100377732C Chinese-medicinal preparation for treating wet beriberi |
| 04/02/2008 | CN100377730C Kidney invigorating and heart nourishing Hongfu ointment |
| 04/02/2008 | CN100377729C Bag with Chinese medicinal powder for treating asthma and cough |
| 04/02/2008 | CN100377722C Liquid-state preparation of Chinese medicine |
| 04/02/2008 | CN100377718C Alcohol-neutralizing agent composition containing hyaluronic acid |
| 04/02/2008 | CN100377716C Preparation method of clindamycin phosphate solution formulation and its applying sheet |
| 04/02/2008 | CN100377712C Cucurbitacin lipsome preparation method and formulation |
| 04/02/2008 | CN100377708C Method for preparing tablet of hydroxy camptothecin and application of oral application |
| 04/02/2008 | CN100377705C Calcium hydrophenyl sulfonate capsule and its preparation process |
| 04/02/2008 | CN100377704C Liposomal formulations |
| 04/01/2008 | US7351798 Stabilized protein crystals, formulations comprising them and methods of making them |
| 04/01/2008 | US7351747 Skin treatment for relief of itch |
| 04/01/2008 | US7351741 4-(4-chloro2-hydroxybenzoylamino)butyric acid or salts for delivering an agent that would otherwise be destroyed or rendered less effective by conditions encountered before the agent reaches its target zone |
| 04/01/2008 | US7351723 aqueous solution with ethylenediaminetetraacetic acid and sodium hydroxide and, or sodium carbonate; regenerated for injection |
| 04/01/2008 | US7351715 Unit dosage forms for the treatment of herpes simplex |
| 04/01/2008 | US7351695 Topiramate sodium, topiramate lithium, topiramate potassium, or polymorphs, solvates, hydrates, dehydrates, co-crystals, anhydrous, and amorphous forms; seizures, obesity, neuropathic pain, affective disorders, tobacco cessation, chronic fatigue syndrome, drug addiction; highly soluble, bioavailability |
| 04/01/2008 | US7351691 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
| 04/01/2008 | US7351688 Compositions and methods for less immunogenic protein formulations |
| 04/01/2008 | US7351554 Administering vaccine, native E7 protein, inactive fragment of the immunosuppressive and/or angiogenic native E7 protein;a DNA molecule encoding immunosuppressive and/or angiogenic native E7 protein inactivated by mutation; adjuvant of mucosal immunity |
| 04/01/2008 | US7351438 Mixing a soft basic gum with an antiagglomerant, a sweetener and other typical chewing-gum ingredient at 35-75 degrees c, cooling at 0--40 degrees c, grinding and screening to a particle size of < 10 mesh, and compressing |
| 04/01/2008 | US7351432 Compositions containing saccharide and hydrophobic silica |
| 04/01/2008 | US7351431 Dissolved cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(alkanoyloxy)]platinum(II) in 2-methyl-2-propanol; stabile, easily handled injection; fine, homogenous suspension; controlled particle size distribution |
| 04/01/2008 | US7351430 Shape-retentive hydrogel particle aggregates and their uses |
| 04/01/2008 | US7351429 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide as an active ingredient, excipient, binder, lubricant and coating agent; uniform in the content of a small amount of active ingredient, excellent light stability; anticholinergic activity on bladder and drug for pollakiuria and urinary incontinence |
| 04/01/2008 | US7351428 Phosphatidyl oligoglycerols |
| 04/01/2008 | US7351427 Biodistribution and reduced side effects; for parenteral administration |
| 04/01/2008 | US7351425 Confectionary product containing functional ingredients |
| 04/01/2008 | US7351422 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 04/01/2008 | US7351415 Gene therapy; vaccines; storage stability; mixture containing viruses |
| 04/01/2008 | US7351413 Stabilized HBc chimer particles as immunogens for chronic hepatitis |
| 04/01/2008 | US7351410 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/01/2008 | US7351406 Aqueous suspension of magnetic latex microspheres and of colloidal nanoparticles of magnetic pigment; mascara, a shaving foam, gel, cream, lotion, shampoo, coating, curling the eyelashes |
| 04/01/2008 | US7351401 Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 04/01/2008 | US7351240 Thermodynamically driven reversible infuser pump for use as a remotely controlled gastric band |
| 04/01/2008 | US7351239 Implantable drug delivery pump |
| 04/01/2008 | US7350676 Valve for aerosol container |
| 04/01/2008 | CA2446574C Liquid pharmaceutical composition |
| 04/01/2008 | CA2414320C Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 04/01/2008 | CA2384885C Particulate vitamin composition |
| 04/01/2008 | CA2372614C Process and product for enhancing immune response in companion animal using a combination of antioxidants |
| 04/01/2008 | CA2363990C Use of glycyrrhizin in the treatment of mastitis |
| 04/01/2008 | CA2316947C Method of manufacturing hard capsules |
| 04/01/2008 | CA2299288C Non-steroidal antiinflammatory drug formulations for topical application to the skin |
| 04/01/2008 | CA2288726C Eyedrops containing a loratadine metabolite |
| 04/01/2008 | CA2278546C Freeze-dried composition of bone morphogenetic protein human mp52 |
| 04/01/2008 | CA2265791C External preparations containing watercress extract |
| 04/01/2008 | CA2231176C Long active composition for rectal administration |
| 04/01/2008 | CA2213368C Polyetherester copolymers as drug delivery matrices |
| 04/01/2008 | CA2149408C Compositions for curing affected abnormal tissues, method for the preparation thereof, and usage thereof |
| 03/27/2008 | WO2008036979A2 Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non-histamine related inflammatory skin changes |
| 03/27/2008 | WO2008036858A2 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| 03/27/2008 | WO2008036855A2 Self-preserved aqueous pharmaceutical compositions |
| 03/27/2008 | WO2008036847A2 Self preserved aqueous pharmaceutical compositions |
| 03/27/2008 | WO2008036809A2 Methods and materials for reducing risk of cold and/or flu |
| 03/27/2008 | WO2008036807A2 Tea-derived compostiions and methods of using same for cardiovascular health |
| 03/27/2008 | WO2008036595A2 Subunguicide, and method for treating onychomycosis |
| 03/27/2008 | WO2008036544A1 Preparation of glassified biological reagents |
| 03/27/2008 | WO2008036429A1 Gallium compositions for the treatment of liver cancer and methods of use |
| 03/27/2008 | WO2008036225A2 Conformable structured therapeutic dressing |
| 03/27/2008 | WO2008036003A1 Pharmaceutical inhalation composition |
| 03/27/2008 | WO2008035962A1 Process and device for the precipitation of an organic compound |
| 03/27/2008 | WO2008035535A1 Capsule including antibacterial agent and artificial joint having the capsule attached thereto |
| 03/27/2008 | WO2008035376A2 A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof |
| 03/27/2008 | WO2008035354A1 Pellets of herbal extracts and process for preparing the same |
| 03/27/2008 | WO2008035128A1 Pharmaceutical compositions containing rosuvastatin calcium |
| 03/27/2008 | WO2008035028A1 Preparation of fine particles |
| 03/27/2008 | WO2008034819A1 Injectable pharmaceutical nimesulide solutions |
| 03/27/2008 | WO2008034767A1 Cationic polymers as thickeners for aqueous and alcoholic compositions |
| 03/27/2008 | WO2008034655A1 Peroral solid pain killer preparation |
| 03/27/2008 | WO2008034533A1 Compositions containing inhibitors of gastro-intestinal lipase |
| 03/27/2008 | WO2008034304A1 Nanometer mesoporous silica-based xerogel styptic material and its preparing process and application |
| 03/27/2008 | WO2008034273A1 Emulsions comprising rubber arabicum |
| 03/27/2008 | WO2008017335A3 Starch silica co-precipitate, method for preparing the same and use thereof |
| 03/27/2008 | WO2008017334A3 Microemulsified drug formulation |
| 03/27/2008 | WO2008012474A3 Pharmaceutical compositions of active substances difficult to improperly divert from their intended route of administration |
| 03/27/2008 | WO2008009361A3 Multicompartment granulate formulations for active substances |
| 03/27/2008 | WO2008008977A3 Nanocrystalline materials for electronic applications |
| 03/27/2008 | WO2008007098A3 Drug delivery polymer with hydrochloride salt of clindamycin |
| 03/27/2008 | WO2008004001A3 The use of pvp to control the release profile of an active ingredient from a hydrophilic polymer matrix tablet |
| 03/27/2008 | WO2007146006A3 Sustained release oxycodone composition with acrylic polymer and a surfactant |
| 03/27/2008 | WO2007133747A3 PULMONARY DELIVERY OF 1α,25-DIHYDROXYVITAMIN D3 AND CO-ADMINISTRATION OF PARATHYROID HORMONE OR CALCITONIN |
| 03/27/2008 | WO2007132296A3 Multilayer tablet |
| 03/27/2008 | WO2007123883A3 Oral dosage formulations and methods of preparing the same |
| 03/27/2008 | WO2007122510A3 Asymmetric membranes for drug delivery devices |